Sort
78,016 grants matching “breast cancer”
Regulation of the DNA damage response by the Mre11 complex
$577,152John Hj Petrini · Sloan-Kettering Inst Can Research · R37 · FY2017 · GM
Image-guided TRAIL-enhanced CAR T-cell immunotherapy
$577,130Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
REPOSITIONING PIMOZIDE FOR BREAST CANCER PREVENTION
$577,119Baylor College Of Medicine · · FY2013 · Department of the Army
VCU Minority-Based CCOP
$577,110John D Roberts · Virginia Commonwealth University · U10 · FY2008 · CA
Heartland Cancer Research CCOP
$577,095Alan P Lyss · Missouri Baptist Medical Center · U10 · FY2012 · CA
BIOLOGICAL FUNCTION OF HUMAN BRCA2 IN THE MOLECULAR ETIOLOGY OF BREAST CANCER
$577,093University Of California, Davis · · FY2013 · Department of Defense
Using Physiological Age to Predict Chemotherapy Toxicity
$577,093Jeanne Mandelblatt · Georgetown University · R01 · FY2010 · CA
Novel roles for p27 as transcriptional co-regulator of cJun in stem cells and development
$577,061Joyce Marie Slingerland · Georgetown University · R01 · FY2022 · CA
Reducing disparities in colorectal cancer screening in Vietnamese Americans
$577,046Bang H Nguyen · Cancer Prevention Instit Of California · R01 · FY2010 · CA
Dissemination of a breast reconstruction decision tool through social media and online communities
$576,993Clara Nan-Hi Lee · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
A nested case-control study of perfluoroalkyl and polyfluoroalkyl substances (PFAS) and breast cancer risk in the Multiethnic Cohort
$576,983Eunjung Lee · University Of Southern California · R01 · FY2025 · CA
REVERSING ANOIKIS RESISTANCE IN TRIPLE NEGATIVE BREAST CANCER
$576,980The Regents Of The University Of Colorado · · FY2013 · Department of Defense
A Portable low-cost, Point of Investigation CapCell Scope to Image and Quantify the Major Axes of Metabolism and the Associated Vasculature in In vitro and In vivo Biological Models
$576,841Nimmi Ramanujam · Duke University · R01 · FY2020 · EB
Senescent CAFs in Breast Cancer Progression
$576,723Sheila A Stewart · Washington University · R01 · FY2025 · AG
Shared Genomic Segment Analysis and Tumor Subtyping in High-Risk BrCa Pedigrees
$576,722Nicola J Camp · University Of Utah · R01 · FY2014 · CA
Shutter-Speed Model DCE-MRI for Assessment of Response to Cancer Therapy
$576,697Wei Huang · Oregon Health & Science University · U01 · FY2015 · CA
Shutter-Speed Model DCE-MRI for Assessment of Response to Cancer Therapy
$576,697Wei Huang · Oregon Health & Science University · U01 · FY2012 · CA
Cancer Caregivers and Their Struggle(s) between Work and Family
$576,680Cathy J. Bradley · University Of Colorado Denver · R01 · FY2022 · CA
RNA circuits for cell state determination in mammalian cells in vitro and in vivo
$576,631Ron Weiss · Massachusetts Institute Of Technology · R01 · FY2020 · CA
(#6) A novel animal model for determining the role of circadian timing in breast cancer development
$576,631H Craig Heller · Stanford University · R01 · FY2019 · CA
Breast Cancer Screening with Quantitative Ultra-Fast DCEMRI and Clinical Risk Assessment
$576,596Gregory S Karczmar · University Of Chicago · R01 · FY2020 · CA
Breast Cancer Screening with Quantitative Ultra-Fast DCEMRI and Clinical Risk Assessment
$576,596Gregory S Karczmar · University Of Chicago · R01 · FY2018 · CA
Breast Cancer Screening with Quantitative Ultra-Fast DCEMRI and Clinical Risk Assessment
$576,596Gregory S Karczmar · University Of Chicago · R01 · FY2021 · CA
(#6) A novel animal model for determining the role of circadian timing in breast cancer development
$576,579H Craig Heller · Stanford University · R01 · FY2020 · CA
(#6) A novel animal model for determining the role of circadian timing in breast cancer development
$576,579H Craig Heller · Stanford University · R01 · FY2021 · CA